Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Gait after total hip replacement: direct anterior vs manual posterior vs robotic posterior

Official title: A Prospective, Single-Blinded, Partially Randomized Three-Cohort Study Comparing Manual Direct Anterior and Manual Posterior Approaches to a Non-Randomized Robotic Posterior Cohort for Total Hip Arthroplasty Using Gait Analysis

Run by Ochsner Health System · NCT07226973 · Data updated 2026-11-12

This study tests whether people having a total hip replacement for osteoarthritis walk and rise from chairs differently when surgeons use a direct anterior approach, a manual posterior approach, or a robotic-assisted posterior approach.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment48 (estimated)
SponsorOchsner Health System
Academic / other
Locations2 sites (Metairie, Louisiana and 1 other locations)
StatusRecruiting
StartedOctober 9, 2025
Main results expectedNovember 15, 2027
Study endsNovember 15, 2027
Registry record updatedNovember 12, 2025
Trial IDNCT07226973 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 with hip osteoarthritis scheduled for a first-time elective total hip replacement, with BMI under 35 and able to walk at least 150 feet unassisted, would be ideal candidates.

Probably not a fit

Patients with prior surgery on the affected hip, neurological conditions that affect gait, or medical contraindications to either approach would not be eligible and are unlikely to benefit from this comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center, three-arm interventional study compares short-term gait biomechanics and patient-reported outcomes after primary total hip arthroplasty performed by direct anterior approach (manual), posterior approach (manual), or robotic-assisted posterior approach. One surgeon randomizes their eligible patients between the manual direct anterior and manual posterior approaches, while a second surgeon performs robotic-assisted posterior procedures per routine practice. Blinded outcome assessors use a Vicon motion-capture system with force plates and surface EMG to measure gait and sit-to-stand mechanics before surgery and at 6 and 12 weeks after surgery. Standard patient-reported outcome instruments are collected to relate biomechanical findings to functional recovery and symptoms.

Why it matters

Potential benefit: If successful, the results could help identify which surgical approach leads to faster or better early walking and functional recovery after hip replacement.

How similar studies have gone: Previous studies have shown robotic assistance can improve implant positioning while comparisons of surgical approaches have produced mixed evidence on short-term gait advantages, so this trial addresses a partially tested but still uncertain area.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged \>18 undergoing primary elective THA for osteoarthritis
* BMI \<35
* Ability to walk unassisted (cane, walker, wheelchair, ect) for \> 150 feet preoperatively

Exclusion Criteria:

* Previous hip surgery on the affected side
* Neurological disorders affecting gait
* Contraindication to either DAA or PA

Where it's running

  • Ochsner Health Center - Elmwood
    Metairie, Louisiana, United States
    Recruiting
  • Ochsner Medical Center
    New Orleans, Louisiana, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.